Phenotypic dichotomies in the foreign body reaction.
To better understand the relationship between macrophage/foreign body giant cell adhesion and activation on surface-modified biomaterials, quantitative assessment of adherent cell density (cells per mm(2)) and cytokine production (pgs per mL) were determined by ELISA. Further analysis to identify cellular activation was carried out by normalizing the cytokine concentration data to provide a measure of cellular activation. This method of analysis demonstrated that hydrophobic surfaces provided statistically significantly greater adherent cell densities than hydrophilic/neutral surfaces. However, when cell activation parameters were determined by normalization to the adherent cell density, the hydrophilic/neutral surfaces demonstrated statistically significantly greater levels of activation and production of IL-10, IL-1beta, IL-6, IL-8, and MIP-1beta. With increasing time, production of the anti-inflammatory cytokine IL-10 increased, whereas IL-1beta, IL-6, and IL-8 decreased and MIP-1beta was relatively constant over the culture time period. This observed dichotomy or disparity between adhesion and activation may be related to surface-induced adherent cell apoptosis. Further evaluation of macrophage activation on biomaterial surfaces indicated that an apparent phenotypic switch in macrophage phenotype occurred over the course of the in vitro culture. Analysis of cytokine/chemokine profiles with surface-modified biomaterials revealed similarities between the classically activated macrophages and the biomaterial-adherent macrophages early (day 3) in culture, while at later timepoints the biomaterial-adherent macrophages produced profiles similar to alternatively activated macrophages. Classically activated macrophages are those commonly activated by lipopolysaccharide (LPS) or interferon-gamma (IFN-gamma) and alternatively activated macrophages are those activated by IL-4/IL-13 or IL-10. Surface modification of biomaterials offer an opportunity to control cellular activation and cytokine profiles in the phenotypic switch, and may provide a means by which macrophages can be induced to regulate particular secretory proteins that direct inflammation, the foreign body reaction, wound healing, and ultimately biocompatibility.
Anderson
James M
JM
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA. jma6@case.edu
Jones
Jacqueline A
JA
D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry*; D002448:Cell Adhesion; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005549:Foreign-Body Reaction; D015726:Giant Cells / Q000378:metabolism; D015743:Giant Cells, Foreign-Body / Q000166:cytology / Q000276:immunology; D006801:Humans; D008262:Macrophage Activation; D008264:Macrophages / Q000378:metabolism; D008422:Materials Testing; D009000:Monocytes / Q000166:cytology; D010641:Phenotype; D014945:Wound Healing
D001672:Biocompatible Materials; D016207:Cytokines
J Biomed Mater Res. 2001 Jun 15;55(4):661-8
11288096
J Biomed Mater Res A. 2008 Jan;84(1):158-66
17607751
Eur J Immunol. 2002 Jul;32(7):2011-20
12115622
Cytokine. 2002 Jun 21;18(6):311-9
12160519
Trends Immunol. 2002 Nov;23(11):549-55
12401408
Nat Rev Immunol. 2003 Jan;3(1):23-35
12511873
J Leukoc Biol. 2003 Feb;73(2):209-12
12554797
J Immunol. 2004 Feb 1;172(3):1407-13
14734716
J Immunol. 1990 Jul 15;145(2):569-75
2114443
J Exp Med. 1992 Jul 1;176(1):287-92
1613462
J Immunol. 1992 Aug 15;149(4):1283-8
1386862
J Immunol. 1997 Apr 1;158(7):3385-90
9120298
Blood. 1998 Oct 15;92(8):2668-71
9763548
Immunology. 1999 Apr;96(4):529-36
10233738
Trends Immunol. 2004 Dec;25(12):677-86
15530839
N Engl J Med. 2006 Feb 9;354(6):610-21
16467548
J Biomed Mater Res A. 2007 Dec 1;83(3):585-96
17503526
Am J Pathol. 2002 Feb;160(2):621-30
11839583